BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9859524)

  • 1. [The choice of the uterine-contraction agent in managing the placental period of labor based on our data].
    Kichukova D; Milchev N; Paskaleva V; Malinova M
    Akush Ginekol (Sofiia); 1998; 37(2):4-6. PubMed ID: 9859524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The side effects of the prevention of blood loss in the placental period].
    Dimitrov A; Nalbanski B; Borisov S; Nikolov A; Dzherov L; Gamishev G
    Akush Ginekol (Sofiia); 1996; 35(3):11-3. PubMed ID: 9045547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active pharmacologic management of the third stage of labor. A comparison of oxytocin and ergometrine.
    Sorbe B
    Obstet Gynecol; 1978 Dec; 52(6):694-7. PubMed ID: 310530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood loss in the placental period in relation to the type of prophylaxis].
    Dimitrov A; Borisov S; Nalbanski B; Nikolov A; Dzherov V; Lazarova L; Gamishev G; Grigorov V
    Akush Ginekol (Sofiia); 1996; 35(3):9-11. PubMed ID: 9045568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention with agents affecting uterine contraction is seldom necessary in the third stage of labor].
    Jilcke P
    Lakartidningen; 1989 Mar; 86(9):736-8. PubMed ID: 2921932
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing postpartum hemorrhage: managing the third stage of labor.
    Maughan KL; Heim SW; Galazka SS
    Am Fam Physician; 2006 Mar; 73(6):1025-8. PubMed ID: 16570736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor.
    Enakpene CA; Morhason-Bello IO; Enakpene EO; Arowojolu AO; Omigbodun AO
    J Obstet Gynaecol Res; 2007 Dec; 33(6):810-7. PubMed ID: 18001447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiology and pathology of the uterine contractile activity in the 3d period of labor].
    Susloparova LA; Ryndin VA
    Vopr Okhr Materin Det; 1979 Jul; 24(7):55-8. PubMed ID: 524790
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-dose sublingual misoprostol versus methylergometrine for active management of the third stage of labor.
    Chhabra S; Tickoo C
    J Obstet Gynaecol Res; 2008 Oct; 34(5):820-3. PubMed ID: 18834340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The active management of the placental period with Remestyp].
    Dimitrov A; Nikolov A; Krŭsteva K; Lazarova L; Gŭrchev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):15-7. PubMed ID: 10726344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The drug management of the placental period induced by traction on the umbilical cord].
    Rehsteiner HP
    Ther Umsch; 1969 Aug; 26(8):450-4. PubMed ID: 5355762
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of postpartum hemorrhage, safety and efficacy.
    Abu-Omar AA
    Saudi Med J; 2001 Dec; 22(12):1118-21. PubMed ID: 11802188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decreased numbers of placental retention after oxytocin compared to methylergometrin].
    Borgvall B; Boström K; Hammar M
    Lakartidningen; 1990 Feb; 87(6):376-7. PubMed ID: 2314178
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
    Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
    Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Administration of uterotonic drugs at the end of the expulsion stage. Comparison of the use of oxytocin and ergometrine maleate].
    Candussi G; Carlomagno G; Bouchè C; Luksa V
    Minerva Ginecol; 1989 Nov; 41(11):535-40. PubMed ID: 2622579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of umbilical vein oxytocin on blood loss and length of third stage of labour.
    Shrestha P; Babu CS
    Nepal Med Coll J; 2007 Sep; 9(3):176-8. PubMed ID: 18092435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific comments on the medicamentous control of the 3d stage of labor].
    Pontuch A; Philadelphy I; Lupták I
    Cesk Gynekol; 1970 Mar; 35(2):121-2. PubMed ID: 5434471
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
    Lam H; Tang OS; Lee CP; Ho PC
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is routine administration of syntometrine still justified in the management of the third stage of labour?
    Rooney I; Hughes P; Calder AA
    Health Bull (Edinb); 1985 May; 43(3):99-101. PubMed ID: 4044247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.